Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accelerate Diagnosti (NQ: AXDX )

0.5807 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.5807
Bid (Size) 0.5800 (7)
Ask (Size) 0.5909 (2)
Prev. Close 0.5807
Today's Range 0.5807 - 0.5807
52wk Range 0.5020 - 9.360
Shares Outstanding 61,498,695
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Accelerate Diagnostics Q1 Earnings
Accelerate Diagnostics (NASDAQ:AXDX) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from... 
Via Benzinga

Performance

YTD
-88.72%
-88.72%
1 Month
-46.23%
-46.23%
3 Month
-76.00%
-76.00%
6 Month
-88.48%
-88.48%
1 Year
-91.55%
-91.55%

More News

Read More
Earnings Scheduled For May 16, 2022
Via Benzinga
Earnings Preview For Accelerate Diagnostics
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2022
Via Benzinga
Accelerate Diagnostics: Q4 Earnings Insights
Via Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
Via Benzinga
Earnings Outlook For Accelerate Diagnostics
Via Benzinga
Insiders Buying Pixelworks And 4 Other Penny Stocks
Via Benzinga
Earnings Scheduled For March 8, 2022
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
51 Biggest Movers From Yesterday
Via Benzinga
4 Penny Stocks Insiders Are Buying: CymaBay Therapeutics, Avalo Therapeutics And More
Via Benzinga
5 Penny Stocks Insiders Are Buying
Via Benzinga
Accelerate Diagnostics Sees Prelim. Q4 Sales $3.3M vs $3.92M Est., FY21 Sales $11.8M vs $12.28M Est.
Via Benzinga
50 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Are These 2 Companies Next for Short Squeezes?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.